BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 4131424)

  • 1. Delayed-hypersensitivity reactions to soluble membrane antigens of human malignant lung cells.
    Hollinshead AC; Stewart TH; Herberman RB
    J Natl Cancer Inst; 1974 Feb; 52(2):327-38. PubMed ID: 4131424
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed hypersensitivity skin reactions to antigens on human tumors.
    Herberman RB
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1469-73. PubMed ID: 4609389
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of lung cancer antigens.
    Hollinshead AC; Sega E; Stewart TH; Ricci C; Mineo TC
    Tumori; 1975; 61(2):125-8. PubMed ID: 179173
    [No Abstract]   [Full Text] [Related]  

  • 4. Skin test in bronchogenic carcinoma. I. Correlation of the immunological status and the extent of the disease.
    Takita H; Brugarolas A
    J Surg Oncol; 1973; 5(4):315-8. PubMed ID: 4355620
    [No Abstract]   [Full Text] [Related]  

  • 5. Isolation and identification of soluble skin-reactive membrane antigens of malignant and normal human breast cells.
    Hollinshead AC; Jaffurs WT; Alpert LK; Harris JE; Herberman RB
    Cancer Res; 1974 Nov; 34(11):2961-8. PubMed ID: 4138143
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship of skin reactive intestinal cancer antigen to the carcinoembryonic antigen of Gold and other antigens.
    Herberman RB; Hollinshead AC; von Kleist S
    Ann Immunol (Paris); 1973 Nov; 124(4):597-8. PubMed ID: 4134476
    [No Abstract]   [Full Text] [Related]  

  • 7. Delayed cutaneous hypersensitivity reactions to membrane extracts of carcinomatous cells of the cervix uteri.
    Wells SA; Melewicz FC; Christiansen C; Ketcham AS
    Surg Gynecol Obstet; 1973 May; 136(5):717-20. PubMed ID: 4701902
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative evaluation of lymphocyte subpopulations, delayed cutaneous hypersensitivity reactions and autoantibody formation in cancer patients.
    Pichler WJ; Stingl G; Wagner G; Micksche M; Neumann H; Knapp W
    Osterr Z Onkol; 1977 Nov; 4(5-6):110-7. PubMed ID: 202907
    [No Abstract]   [Full Text] [Related]  

  • 9. Delayed cutaneous hypersensitivity reactions to tumor cell antigens and to nonspecific antigens. Prognostic significance in patients with lung cancer.
    Wells SA; Burdick JF; Joseph WL; Christiansen CL; Wolfe WG; Adkins PC
    J Thorac Cardiovasc Surg; 1973 Oct; 66(4):557-62. PubMed ID: 4755446
    [No Abstract]   [Full Text] [Related]  

  • 10. A novel monoclonal antibody-defined antigen which distinguishes human non-small cell from small cell lung carcinomas.
    Sobol RE; Peters RE; Astarita RW; Hofeditz C; Masui H; Burton D; Handley HH; Glassy MC; Fairshter R; Carlo DJ
    Cancer Res; 1986 Sep; 46(9):4746-50. PubMed ID: 3015395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic studies of glycoproteins isolated from cell membranes of human lung carcinomas.
    Tillack TW; Rosai J; Vervynck DJ
    J Natl Cancer Inst; 1974 Apr; 52(4):1059-67. PubMed ID: 4133198
    [No Abstract]   [Full Text] [Related]  

  • 12. [Carcinoembryonic antigen (CEA) in the blood serum of patients with primary bronchial cancer].
    Kozielski J; Seweryn J
    Pol Tyg Lek; 1985 Jan; 40(1):5-8. PubMed ID: 2983292
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo and in vitro assays of cellular immunity to human tumor antigens.
    Herberman RB
    Fed Proc; 1973 Feb; 32(2):160-4. PubMed ID: 4120197
    [No Abstract]   [Full Text] [Related]  

  • 14. Delayed cutaneous hypersensitivity reactions to extracts of human tumors.
    Herberman RB; Hollinshead AC; Alford TC; McCoy JL; Halterman RH; Leventhal BG
    Natl Cancer Inst Monogr; 1973 Jun; 37():189-95. PubMed ID: 4123453
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor associated antigen with pulmonary neoplasms.
    Lo Gerfo P; Herter FP; Braun J; Hansen HJ
    Ann Surg; 1972 Apr; 175(4):495-500. PubMed ID: 4336486
    [No Abstract]   [Full Text] [Related]  

  • 16. The prognostic significance of DHS skin tests in patients with carcinoma of bronchus.
    Anthony HM; Templeman GH; Madsen KE; Mason MK
    Cancer; 1974 Dec; 34(6):1901-6. PubMed ID: 4373163
    [No Abstract]   [Full Text] [Related]  

  • 17. Delayed hypersensitivity in patients with bronchial carcinoma.
    Pauwels R; van der Straeten M
    Scand J Respir Dis; 1975 Sep; 56(3):160-4. PubMed ID: 1162307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of endodermally derived and neural crest-derived differentiation antigens by human lung and colon tumors.
    Bell CE; Seetharam S
    Cancer; 1979 Jul; 44(1):13-8. PubMed ID: 88254
    [No Abstract]   [Full Text] [Related]  

  • 19. A plasma membrane antigen highly associated with oat-cell carcinoma of the lung and undetectable in normal adult tissue.
    Bell CE; Seetharam S
    Int J Cancer; 1976 Nov; 18(5):605-11. PubMed ID: 62723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble membrane antigens of human malignant melanoma cells.
    Hollinshead AC; Herberman RB; Jaffurs WJ; Alpert LK; Minton JP; Harris JE
    Cancer; 1974 Oct; 34(4):1235-43. PubMed ID: 4418174
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.